Physicians have gone in the last 15 years from being afraid to recommend exercise to cancer patients to advising them to exercise, U.S. researchers say. Karen Mustian, an assistant professor of radiation oncology at the University of Rochester Medical Center in New York, and colleagues said when patients walk in the door, they want to know how to tailor exercise to their situation. "The scientific community has not settled into a place where we've developed explicit exercise prescriptions, or can effectively narrow the choices for patients," Mustian said in a statement. Mustian conducted a phase II clinical trial to discover whether six weeks of a home-based exercise plan -- walking and resistance bands -- improved cancer-related fatigue and strength in 58 men, mean age 67, with prostate cancer who were treated with radiation and androgen deprivation therapy. The men ranged in fitness from frail to golfers who were fit and active. A control group that did no exercise was also established. Researchers measured cardiopulmonary function via a gold-standard test called Vo2-peak, and also measured muscular strength, and found all exercisers improved while the control group declined in performance. The most significant information, Mustian said, was that everyone who exercised regularly achieved some added benefit -- even the fittest participants. The findings will be discussed at the American Society of Clinical Oncology annual meeting in Chicago.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor